ScholarIQanswers from OpenAlex

MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts

PaperCitations, authors & open-access status

MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts is a paper indexed in ScholarIQ from OpenAlex.

How many citations does MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts have?

ScholarIQcitation count

MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts has 2,353 citations in the OpenAlex counts ScholarIQ stores.

When was MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts published?

ScholarIQyear

MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts has 2008 year in the ScholarIQ index.

What is the open-access status of MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts?

ScholarIQoa status

MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts has closed oa status in the ScholarIQ index.

What is the DOI of MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts?

ScholarIQdoi

The DOI for MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts is on the source record.

What is the PMID of MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts?

ScholarIQpmid

The PMID for MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts is on the source record.

What is the OpenAlex record for MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts?

ScholarIQopenalex

The OpenAlex for MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial